The solute carrier 6 family of transporters

被引：181

作者：

Broeer, Stefan ^{[1
]}

Gether, Ulrik ^{[2
]}

机构：

[1] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia

[2] Univ Copenhagen, Panum Inst, Fac Hlth Sci, Mol Neuropharmacol Grp,Dept Neurosc & Pharmacol, Copenhagen, Denmark

来源：

BRITISH JOURNAL OF PHARMACOLOGY | 2012年 / 167卷 / 02期

关键词：

monoamine transporters; antidepressants; transport mechanism; transporter pharmacology; AMINOBUTYRIC-ACID TRANSPORTER; HUMAN DOPAMINE TRANSPORTER; DEFICIT HYPERACTIVITY DISORDER; HUMAN SEROTONIN TRANSPORTER; HUMAN NORADRENALINE TRANSPORTER; INDUCED REVERSE TRANSPORT; HIGH-AFFINITY RECOGNITION; L-PROLINE TRANSPORTER; GLYCINE TRANSPORTER; NEUROTRANSMITTER TRANSPORTERS;

D O I：

10.1111/j.1476-5381.2012.01975.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The solute carrier 6 (SLC6) family of the human genome comprises transporters for neurotransmitters, amino acids, osmolytes and energy metabolites. Members of this family play critical roles in neurotransmission, cellular and whole body homeostasis. Malfunction or altered expression of these transporters is associated with a variety of diseases. Pharmacological inhibition of the neurotransmitter transporters in this family is an important strategy in the management of neurological and psychiatric disorders. This review provides an overview of the biochemical and pharmacological properties of the SLC6 family transporters. LINKED ARTICLES BJP published a themed section on Transporters in 2011. To view articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.2011.164.issue-7/issuetoc

引用

页码：256 / 278

页数：23

共 232 条

[1] Structure and function of Na+-symporters with inverted repeats
Abramson, Jeff
Wright, Ernest M.
[J]. CURRENT OPINION IN STRUCTURAL BIOLOGY, 2009, 19 (04) : 425 - 432
[2] Novel N-substituted 3α-[bis(4′-fluorophenyl)methoxy]tropane analogues:: Selective ligands for the dopamine transporter
Agoston, GE
Wu, JH
Izenwasser, S
George, C
Katz, J
Kline, RH
Newman, AH
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (26) : 4329 - 4339
[3] Special Issue: Guide to Receptors and Channels, 5th Edition Abstracts
Alexander, Stephen P. H.
Mathie, Alistair
Peters, John A.
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 2011, 164 : S1 - +
[4] Molecular determinants for selective recognition of antidepressants in the human serotonin and norepinephrine transporters
Andersen, Jacob
Stuhr-Hansen, Nicolai
Zachariassen, Linda
Toubro, Soren
Hansen, Stinna M. R.
Eildal, Jonas N. N.
Bond, Andrew D.
Bogeso, Klaus P.
Bang-Andersen, Benny
Kristensen, Anders S.
Stromgaard, Kristian
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (29) : 12137 - 12142
[5] Recent advances in the understanding of the interaction of antidepressant drugs with serotonin and norepinephrine transporters
Andersen, Jacob
Kristensen, Anders S.
Bang-Andersen, Benny
Stromgaard, Kristian
[J]. CHEMICAL COMMUNICATIONS, 2009, (25) : 3677 - 3692
[6] Apparsundaram S, 2001, J PHARMACOL EXP THER, V299, P666
[7] Glycine transporters:: crucial roles of pharmacological interest revealed by gene deletion
Aragón, C
López-Corcuera, B
[J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (06) : 283 - 286
[8] The C-terminal PDZ-ligand motif of the neuronal glycine transporter GlyT2 is required for efficient synaptic localization
Armsen, Wencke
Himmel, Bettina
Betz, Heinrich
Eulenburg, Volker
[J]. MOLECULAR AND CELLULAR NEUROSCIENCE, 2007, 36 (03) : 369 - 380
[9] High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis - An aromatic residue in transmembrane domain I dictates species-selective recognition of citalopram and mazindol
Barker, EL
Perlman, MA
Adkins, EM
Houlihan, WJ
Pristupa, ZB
Niznik, HB
Blakely, RD
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (31) : 19459 - 19468
[10] Beckman ML, 1998, J NEUROSCI, V18, P6103

← 1 2 3 4 5 6 7 8 9 10 →